questionsmedicales.fr
Régions géographiques
Asie
Asie du Sud-Est
Vietnam
Vietnam : Questions médicales fréquentes
Termes MeSH sélectionnés :
Percutaneous Coronary Intervention
Diagnostic
5
Dengue
Diagnostic médical
Paludisme
Tests de diagnostic
Tuberculose
Diagnostic médical
Choléra
Diagnostic médical
Complications
5
Tuberculose
Complications
Facteurs de risque
5
Dengue
Facteurs de risque
Paludisme
Facteurs de risque
Tuberculose
Facteurs de risque
Choléra
Facteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vietnam : Questions médicales les plus fréquentes",
"headline": "Vietnam : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vietnam : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-12",
"dateModified": "2025-05-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vietnam"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Asie du Sud-Est",
"url": "https://questionsmedicales.fr/mesh/D001210",
"about": {
"@type": "MedicalCondition",
"name": "Asie du Sud-Est",
"code": {
"@type": "MedicalCode",
"code": "D001210",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.252.145"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Vietnam",
"alternateName": "Vietnam",
"code": {
"@type": "MedicalCode",
"code": "D014744",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Pham Quang Thai",
"url": "https://questionsmedicales.fr/author/Pham%20Quang%20Thai",
"affiliation": {
"@type": "Organization",
"name": "National Institute of Hygiene and Epidemiology, Hanoi, Viet Nam; School of Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, Viet Nam."
}
},
{
"@type": "Person",
"name": "Le Van Tan",
"url": "https://questionsmedicales.fr/author/Le%20Van%20Tan",
"affiliation": {
"@type": "Organization",
"name": "Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam."
}
},
{
"@type": "Person",
"name": "Marc Choisy",
"url": "https://questionsmedicales.fr/author/Marc%20Choisy",
"affiliation": {
"@type": "Organization",
"name": "Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam; Centre for Global Health and Tropical Medicine, University of Oxford, UK."
}
},
{
"@type": "Person",
"name": "H Rogier van Doorn",
"url": "https://questionsmedicales.fr/author/H%20Rogier%20van%20Doorn",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "H T Nguyen",
"url": "https://questionsmedicales.fr/author/H%20T%20Nguyen",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Percutaneous Coronary Interventions in Women.",
"datePublished": "2023-10-10",
"url": "https://questionsmedicales.fr/article/37815649",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11883-023-01150-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Calcium Modification in Percutaneous Coronary Interventions.",
"datePublished": "2022-09-15",
"url": "https://questionsmedicales.fr/article/36243483",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.iccl.2022.06.001"
}
},
{
"@type": "ScholarlyArticle",
"name": "Percutaneous coronary intervention of bifurcation lesions.",
"datePublished": "2022-07-22",
"url": "https://questionsmedicales.fr/article/35866256",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4244/EIJ-D-21-01065"
}
},
{
"@type": "ScholarlyArticle",
"name": "Impact of Multivessel Percutaneous Coronary Intervention vs. Culprit Vessel Percutaneous Coronary Intervention in Patients with Acute Coronary Syndromes and Multivessel Coronary Artery Disease.",
"datePublished": "2023-03-01",
"url": "https://questionsmedicales.fr/article/36890057",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.carrev.2023.02.024"
}
},
{
"@type": "ScholarlyArticle",
"name": "Smoking cessation after coronary angiography and percutaneous coronary intervention.",
"datePublished": "2022-08-25",
"url": "https://questionsmedicales.fr/article/36026609",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.20452/pamw.16328"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Régions géographiques",
"item": "https://questionsmedicales.fr/mesh/D005842"
},
{
"@type": "ListItem",
"position": 3,
"name": "Asie",
"item": "https://questionsmedicales.fr/mesh/D001208"
},
{
"@type": "ListItem",
"position": 4,
"name": "Asie du Sud-Est",
"item": "https://questionsmedicales.fr/mesh/D001210"
},
{
"@type": "ListItem",
"position": 5,
"name": "Vietnam",
"item": "https://questionsmedicales.fr/mesh/D014744"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vietnam - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vietnam",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vietnam",
"description": "Comment diagnostiquer la dengue au Vietnam ?\nQuels tests pour le paludisme au Vietnam ?\nComment identifier la tuberculose ?\nQuels signes pour le choléra ?\nComment détecter une infection à VIH ?",
"url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Percutaneous+Coronary+Intervention#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vietnam",
"description": "Quels symptômes de la dengue ?\nQuels signes du paludisme ?\nQuels symptômes de la tuberculose ?\nQuels signes du choléra ?\nQuels symptômes d'une infection à VIH ?",
"url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Percutaneous+Coronary+Intervention#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vietnam",
"description": "Comment prévenir la dengue ?\nQuelles mesures pour prévenir le paludisme ?\nComment prévenir la tuberculose ?\nQuelles précautions contre le choléra ?\nComment prévenir le VIH ?",
"url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Percutaneous+Coronary+Intervention#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vietnam",
"description": "Quel traitement pour la dengue ?\nComment traiter le paludisme ?\nQuel traitement pour la tuberculose ?\nComment traiter le choléra ?\nQuel traitement pour le VIH ?",
"url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Percutaneous+Coronary+Intervention#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vietnam",
"description": "Quelles complications de la dengue ?\nQuelles complications du paludisme ?\nQuelles complications de la tuberculose ?\nQuelles complications du choléra ?\nQuelles complications du VIH ?",
"url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Percutaneous+Coronary+Intervention#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vietnam",
"description": "Quels facteurs de risque pour la dengue ?\nQuels facteurs de risque pour le paludisme ?\nQuels facteurs de risque pour la tuberculose ?\nQuels facteurs de risque pour le choléra ?\nQuels facteurs de risque pour le VIH ?",
"url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Percutaneous+Coronary+Intervention#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la dengue au Vietnam ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins pour détecter les anticorps ou l'ARN viral."
}
},
{
"@type": "Question",
"name": "Quels tests pour le paludisme au Vietnam ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un frottis sanguin ou un test de diagnostic rapide sont utilisés pour le paludisme."
}
},
{
"@type": "Question",
"name": "Comment identifier la tuberculose ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "La tuberculose est diagnostiquée par des tests cutanés, des radiographies et des cultures."
}
},
{
"@type": "Question",
"name": "Quels signes pour le choléra ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le choléra se diagnostique par des selles liquides et des tests de laboratoire."
}
},
{
"@type": "Question",
"name": "Comment détecter une infection à VIH ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins spécifiques détectent les anticorps ou l'ARN du VIH."
}
},
{
"@type": "Question",
"name": "Quels symptômes de la dengue ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, douleurs articulaires, éruptions cutanées et fatigue sont fréquents."
}
},
{
"@type": "Question",
"name": "Quels signes du paludisme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, frissons, sueurs, maux de tête et douleurs musculaires sont typiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes de la tuberculose ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Toux persistante, perte de poids, sueurs nocturnes et fatigue sont courants."
}
},
{
"@type": "Question",
"name": "Quels signes du choléra ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Diarrhée aqueuse sévère, vomissements et déshydratation rapide sont caractéristiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une infection à VIH ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Symptômes initiaux incluent fièvre, fatigue, éruptions cutanées et ganglions enflés."
}
},
{
"@type": "Question",
"name": "Comment prévenir la dengue ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éliminer les eaux stagnantes et utiliser des répulsifs contre les moustiques."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour prévenir le paludisme ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des moustiquaires, des insecticides et prendre des médicaments préventifs."
}
},
{
"@type": "Question",
"name": "Comment prévenir la tuberculose ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Vaccination BCG et dépistage des cas contacts sont essentiels pour la prévention."
}
},
{
"@type": "Question",
"name": "Quelles précautions contre le choléra ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Boire de l'eau potable, se laver les mains et consommer des aliments cuits."
}
},
{
"@type": "Question",
"name": "Comment prévenir le VIH ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des préservatifs et se faire dépister régulièrement pour prévenir le VIH."
}
},
{
"@type": "Question",
"name": "Quel traitement pour la dengue ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement est symptomatique, avec des analgésiques et une hydratation adéquate."
}
},
{
"@type": "Question",
"name": "Comment traiter le paludisme ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments antipaludiques comme l'artémisinine sont utilisés pour traiter le paludisme."
}
},
{
"@type": "Question",
"name": "Quel traitement pour la tuberculose ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La tuberculose nécessite un traitement antibiotique prolongé, souvent sur six mois."
}
},
{
"@type": "Question",
"name": "Comment traiter le choléra ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le choléra est traité par réhydratation orale ou intraveineuse et antibiotiques si nécessaire."
}
},
{
"@type": "Question",
"name": "Quel traitement pour le VIH ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le VIH est traité par des antirétroviraux pour contrôler la charge virale."
}
},
{
"@type": "Question",
"name": "Quelles complications de la dengue ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la dengue sévère, le choc et des hémorragies."
}
},
{
"@type": "Question",
"name": "Quelles complications du paludisme ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le paludisme peut entraîner des anémies, des convulsions et des défaillances organiques."
}
},
{
"@type": "Question",
"name": "Quelles complications de la tuberculose ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la dissémination à d'autres organes et la résistance aux médicaments."
}
},
{
"@type": "Question",
"name": "Quelles complications du choléra ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "La déshydratation sévère peut entraîner un choc hypovolémique et la mort."
}
},
{
"@type": "Question",
"name": "Quelles complications du VIH ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le VIH peut mener à des infections opportunistes et à des cancers associés."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour la dengue ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Vivre dans des zones tropicales, exposition aux moustiques et manque d'assainissement."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour le paludisme ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Vivre dans des zones endémiques, absence de protection contre les moustiques."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour la tuberculose ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Conditions de vie précaires, immunodépression et contact avec des malades."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour le choléra ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Accès limité à l'eau potable et à l'assainissement, ainsi que la consommation d'aliments contaminés."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour le VIH ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Relations sexuelles non protégées, partage de seringues et absence de dépistage."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 07/05/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
National Institute of Hygiene and Epidemiology, Hanoi, Viet Nam; School of Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, Viet Nam.
Publications dans "Vietnam" :
3 publications dans cette catégorie
Affiliations :
Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam.
Publications dans "Vietnam" :
3 publications dans cette catégorie
Affiliations :
Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam; Centre for Global Health and Tropical Medicine, University of Oxford, UK.
Publications dans "Vietnam" :
3 publications dans cette catégorie
Publications dans "Vietnam" :
3 publications dans cette catégorie
Publications dans "Vietnam" :
3 publications dans cette catégorie
Affiliations :
School of Biomedical Sciences, The University of Western Australia, Crawley, WA, Australia.
Publications dans "Vietnam" :
3 publications dans cette catégorie
Affiliations :
Thai Binh University of Medicine and Pharmacy, Thai Binh, Viet Nam.
Publications dans "Vietnam" :
3 publications dans cette catégorie
Affiliations :
School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia.
Publications dans "Vietnam" :
3 publications dans cette catégorie
Affiliations :
School of Biomedical Sciences, The University of Western Australia, Crawley, WA, Australia; School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia; Medical, Molecular and Forensic Sciences, Murdoch University, Murdoch, WA, Australia; PathWest Laboratory Medicine, Department of Microbiology, Nedlands, WA, Australia. Electronic address: thomas.riley@uwa.edu.au.
Publications dans "Vietnam" :
2 publications dans cette catégorie
Affiliations :
Department of Organization and Drug Administration, Faculty of Pharmacy, University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam.
Publications dans "Vietnam" :
2 publications dans cette catégorie
Affiliations :
Hanoi Medical University, 1 Ton That Tung, Dong Da, Hanoi, 100000, Vietnam. buimyhanh@hmu.edu.vn.
Hanoi Medical University Hospital, 1 Ton That Tung, Dong Da, Hanoi, 100000, Vietnam. buimyhanh@hmu.edu.vn.
Publications dans "Vietnam" :
2 publications dans cette catégorie
Affiliations :
Hanoi University of Public Health, 1A Duc Thang, North Tu Liem, Hanoi, 100000, Vietnam.
Publications dans "Vietnam" :
2 publications dans cette catégorie
Affiliations :
Division of Cancer Control and Population Sciences, University of Pittsburgh Medical Center Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA.
Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA.
Publications dans "Vietnam" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Diagnostics and Epidemiology, Central Research Institute of Epidemiology, 111123 Moscow, Russia.
Publications dans "Vietnam" :
2 publications dans cette catégorie
Affiliations :
Biomedicine Institute, Joint Vietnam-Russia Tropical Science and Technology Research Center, Hanoi 122000, Vietnam.
Publications dans "Vietnam" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Diagnostics and Epidemiology, Central Research Institute of Epidemiology, 111123 Moscow, Russia.
Publications dans "Vietnam" :
2 publications dans cette catégorie
Affiliations :
Biomedicine Institute, Joint Vietnam-Russia Tropical Science and Technology Research Center, Hanoi 122000, Vietnam.
Publications dans "Vietnam" :
2 publications dans cette catégorie
Affiliations :
National Institute of Malariology, Parasitology and Entomology, Hanoi 110000, Vietnam.
Publications dans "Vietnam" :
2 publications dans cette catégorie
Affiliations :
Southern Branch of Joint Vietnam-Russia Tropical Science and Technology Research Center, Ho Chi Minh City 740500, Vietnam.
Publications dans "Vietnam" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Diagnostics and Epidemiology, Central Research Institute of Epidemiology, 111123 Moscow, Russia.
Publications dans "Vietnam" :
Cardiovascular disease is the leading cause of morbidity and mortality among women globally. Numerous studies show ongoing disparities in diagnosis, management, and outcomes of ischemic heart disease ...
Hormonal influence on coronary arteries and progression of atherosclerosis in women results in distinct coronary plaque characteristics and unique pathological process such as spontaneous coronary art...
Moderate-severe calcification increases procedural complications and impairs long-term prognosis post-PCI. Intravascular imaging (particularly optical coherence tomography [OCT]) is useful in guiding ...
Bifurcation coronary artery disease is common as the development of atherosclerosis is facilitated by altered endothelial shear stress. Multiple anatomical and physiological factors need to be conside...
Recent clinical trials have shown that percutaneous coronary intervention (PCI) for non-culprit lesions (NCLs) reduces the risk of adverse events in patients with ST-segment elevation myocardial infar...
A retrospective observational cohort study of ACS patients who underwent primary PCI between April 2004 and December 2017 at Juntendo University Shizuoka Hospital, Japan, was performed. The primary en...
Of the 1109 ACS patients with multivessel coronary artery disease of the current cohort, multivessel PCI was performed in 364 (33.2 %) patients. The incidence of the primary endpoint from 31 days to 5...
In ACS patients with multivessel coronary artery disease, multivessel PCI may reduce the risk of CVD death and non-fatal MI compared to culprit-lesion-only PCI....
Smoking is a crucial modifiable risk factor for coronary artery disease. However, effective support in smoking cessation (SC) and data regarding factors related to SC are still inadequate....
We aimed to assess SC rates and factors related to effective SC in patients after coronary angiography (CA)....
Patients who underwent CA between 2014 and 2018 at a single center in Poland were screened for active smoking. After at least 6 months after the procedure, the patients were contacted by telephone to ...
A total of 3719 consecutive patients were screened. Of these, 921 (24.8%) declared active smoking. At least 6 months after CA, 241 patients were available for a follow‑up interview. The mean (SD) age ...
A substantial number of patients who underwent CA were current smokers, with low SC rates in the follow‑up. A prolonged hospital stay, scheduled second hospitalization, low nicotine dependence but als...
Coronary disease carries significant morbidity and mortality globally. The pandemic of obesity and diabetes combined with an aging population have resulted in a significant proportion of patients with...
Dyspnea is a frequent symptom in patients with stable coronary artery disease (CAD) and is recognized as a possible angina equivalent....
This study was to assess the impact of percutaneous coronary intervention (PCI) on dyspnea, quality of life, and angina pectoris in patients with stable CAD....
The prospective, multi-center PLA-pCi-EBO-pilot trial included 144 patients with symptomatic stable CAD and successful PCI. The prespecified endpoints angina pectoris (Seattle Angina Questionnaire-SAQ...
Patients with concomitant dyspnea had worse SAQ physical limitation scores at baseline (49.5 ± 21.0 vs 58.9 ± 22.0, p = 0.013) but showed no difference for angina frequency or quality of life. Overall...
PCI effectively reduced dyspnea, which is a frequent and demanding symptom in patients with CAD. The German Clinical Trials Register registration number is DRKS0001752 ( www.drks.de )....
A deeper understanding of coronary medial thickness is important for coronary intervention because media thickness can limit the safety and effectiveness of interventional techniques. However, there i...
We investigated the thickness of the media by histologic analysis. A total of 230 sections from 10 individuals from the CVPath autopsy registry who died from non-coronary deaths were evaluated. We per...
The average age of the studied individuals was 60.4±12.3 years. The median medial thickness for all sections was 0.202 (0.149-0.263) mm. The median medial thickness of the main branches was significan...
The human coronary arteries demonstrate variation in medial thickness which tends to vary depending upon an epicardial coronary artery itself, as well as its segments and branches. Understanding these...
Data comparing patients who undergo multiarterial grafting during coronary artery bypass grafting (CABG) vs percutaneous coronary intervention (PCI) in patients with multivessel coronary disease are s...
This retrospective study included all patients with coronary artery disease who underwent CABG with multiple arterial conduits or PCI. Propensity score matching was performed for baseline characterist...
The total patient population consisted of 3648 patients from 2011 to 2018 divided into 902 CABG patients and 2746 PCI patients. Patients were propensity matched (PCI, n = 838; CABG, n = 838). In the C...
Patients with coronary artery disease who undergo CABG with multiple arterial conduits have significantly fewer major adverse events, improved survival, and reduced hospital readmissions....
Background Complex percutaneous coronary intervention (PCI) is increasingly performed in older adults (age ≥75 years) with stable ischemic heart disease. However, little is known about clinical outcom...